Antiprogestins could be a very promising group of compounds for contraception because they counteract the effects of progesterone, a key hormone for normal reproductive functioning. Great efforts have therefore been devoted to testing various ways of using these compounds for family planning. Most of this work has involved mifepristone; other antiprogestins have not been available for trials. With a few exceptions, the outcome of the studies performed to date has not met expectations. The most promising approaches seem to be the use of antiprogestins for emergency contraception, perhaps also as a daily pill when the dose is high enough to block ovulation, and in sequential regimens followed by a progestin. Given that antiprogestins differ in their affinity for target organs, better results could possibly be achieved by using more specific compounds than mifepristone. It is hoped that a wider choice of antiprogestational compounds will soon become available for research.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1055/s-2005-864037 | DOI Listing |
J Hazard Mater
December 2024
University of South Bohemia in České Budějovice, Faculty of Fisheries and Protection of Waters, South Bohemian Research Center of Aquaculture and Biodiversity of Hydrocenoses, Research Institute of Fish Culture and Hydrobiology, Zátiší 728/II, 38925 Vodňany, Czech Republic. Electronic address:
This is the first study on how a substance with anti-progestogenic activity affects amphibian reproduction. Mifepristone, a synthetic anti-progestin used in abortion pills, was chosen as model compound. African clawed frog (Xenopus laevis) females were exposed to four mifepristone concentrations (0.
View Article and Find Full Text PDFVet Med Sci
November 2024
Division Theriogenology, Faculty of Veterinary Medicine, Khon Kaen University, Khon Kaen, Thailand.
Feline mammary fibroadenomatous hyperplasia (FMFH) is an extensive proliferation of feline mammary tissues in response to endogenous or exogenous progestogens. The treatment of choice for FMFH is anti-progestins or ovariohysterectomy (OVH). OVH if there is no intention of breeding the queen.
View Article and Find Full Text PDFInt J Mol Sci
July 2024
Department of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.
Progesterone receptor antagonism is gaining attention due to progesterone's recognized role as a major mitogen in breast tissue. Limited but promising data suggest the potential efficacy of antiprogestins in breast cancer prevention. The present study presents secondary outcomes from a randomized controlled trial and examines changes in breast mRNA expression following mifepristone treatment in healthy premenopausal women.
View Article and Find Full Text PDFVaccines (Basel)
May 2024
HSF Pharmaceuticals SA, 1814 La Tour-de-Peilz, Switzerland.
A universal vaccine that generally prevents influenza virus infection and/or illness remains elusive. We have been exploring a novel approach to vaccination involving replication-competent controlled herpesviruses (RCCVs) that can be deliberately activated to replicate efficiently but only transiently in an administration site in the skin of a subject. The RCCVs are derived from a virulent wild-type herpesvirus strain that has been engineered to contain a heat shock promoter-based gene switch that controls the expression of, typically, two replication-essential viral genes.
View Article and Find Full Text PDFJ Steroid Biochem Mol Biol
July 2024
Laboratory of Hormonal Carcinogenesis, Instituto de Biología y Medicina Experimental (IBYME CONICET), Buenos Aires, Argentina. Electronic address:
The development of antiprogestins was initially a gynecological purpose. However, since mifepristone was developed, its application for breast cancer treatment was immediately proposed. Later, new compounds with lower antiglucocorticoid and antiandrogenic effects were developed to be applied to different pathologies, including breast cancer.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!